syndrome (RLS), and 10 controls age-matched to each RLS group separately were
examined with polysomnography (PSG),[123I]-(N)-(3-iodopropen-2-yl)-2β-carbomethoxy-3β-
(4-chlorophenyl) tropane (123I-IPT) SPECT, and [123I]-(S)-2-hydroxy-3-iodo-6-methoxy-[(1-
ethyl-2-pyrrolidinyl) methyl] benzamide (123I-IBZM) SPECT. Drug-naive and levodopa-
treated patients with RLS and controls showed similar striatal dopamine transporter and …